, Tracking Stock Market Picks
Enter Symbol:
Esperion Therapeutics Inc. (ESPR) [hlAlert]

down 49.44 %

Esperion Therapeutics Inc. (ESPR) rated Buy with price target $140 by UBS

Posted on: Wednesday,  Apr 1, 2015  1:25 PM ET by UBS

UBS rated Buy Esperion Therapeutics Inc. (NASDAQ: ESPR) on 04/01/2015, when the stock price was $102.87. Since
then, Esperion Therapeutics Inc. has lost 49.44% as of 01/05/2016's recent price of $52.01.
If you would have followed this UBS's recommendation on ESPR, you would have lost 49.44% of your investment in 279 days.

UBS is the leading global wealth manager, a top tier investment banking and securities firm, and one of the largest global asset managers. In Switzerland, UBS is the market leader in retail and commercial banking. With headquarters in Zurich and Basel, Switzerland, UBS operates in over 50 countries and from all major international centers. UBS employs more than 80,000 people.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
4/1/2015 1:25 PM Buy
102.87 140.00
as of 8/27/2015
1 Week down  -11.45 %
1 Month down  -35.76 %
3 Months down  -51.72 %
1 YTD down  -49.44 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy